Global isoniazid resistance patterns in rifampin-resistant and rifampin-susceptible tuberculosis

Smith, Sarah E; Kurbatova, Ekaterina V; Cavanaugh, Joseph S; Cegielski, J Peter

Back to Previous Page

Global isoniazid resistance patterns in rifampin-resistant and rifampin-susceptible tuberculosis

Published Date:

2012 Feb

Source:

Int J Tuberc Lung Dis. 16(2):203-205

Language:

English

[PDF-96.51 KB]

Details:

Alternative Title:

Int J Tuberc Lung Dis

Personal Author:

Smith, Sarah E ; Kurbatova, Ekaterina V ; Cavanaugh, Joseph S ; Cegielski, J Peter ;

Description:

Following the World Health Organization's endorsement of the Xpert® MTB/RIF assay, which rapidly and simultaneously diagnoses tuberculosis (TB) and detects resistance to rifampin (RMP), the question arises to what extent RMP resistance is an adequate marker for multidrug-resistant TB (MDR-TB). A retrospective analysis of data from >81 countries and subnational settings demonstrated that >40% of RMP-resistant isolates from new TB cases did not display resistance to isoniazid (INH) in settings with relatively low MDR-TB prevalence (one third of all countries and subnational settings). Results indicated the need for INH susceptibility testing in addition to RMP susceptibility testing.

Subject:

[+]

Pubmed ID:

22136739

Pubmed Central ID:

PMC4593497

Document Type:

Journal Article

Funding:

CC999999/Intramural CDC HHS/United States

Collection(s):

CDC Public Access

Main Document Checksum:

[+]

File Type:

Supporting Files:

nihms725526.nxml

text/xml

No Related Documents.

RIFAMPIN-RESISTANT TUBERCULOSIS IN THE UNITED STATES, 1998–2014

[PDF - 393.81 KB]

Personal Author:

Sharling, Lisa ; Marks, Suzanne M. ; ...

Published Date:

April 10 2020

Source:

Clin Infect Dis. 70(8):1596-1605

Description:

BackgroundMonoresistance to rifamycins necessitates longer and more toxic regimens for tuberculosis (TB). We examined characteristics and mortality as...

File Type:

[PDF - 393.81 KB]

File Type:

[PDF - 393.81 KB]
More on Treatment Outcomes in Multidrug-Resistant Tuberculosis

[PDF - 27.00 KB]

Personal Author:

Brust, James C.M. ; Shah, N. Sarita ; ...

Published Date:

Dec 29 2016

Source:

N Engl J Med. 375(26):2610.

File Type:

[PDF - 27.00 KB]

File Type:

[PDF - 27.00 KB]
The disconnect between a national tuberculosis drug resistance survey and treatment outcomes: a lost opportunity

[PDF - 239.87 KB]

Personal Author:

Click, E. S. ; Chirenda, J. ; ...

Published Date:

Nov 2014

Source:

Int J Tuberc Lung Dis. 18(11):1319-1322

Description:

We linked results from the Fourth Botswana National Drug Resistance Survey (DRS), 2007-2008, to patient records from the national Electronic Tuberculo...

File Type:

[PDF - 239.87 KB]

File Type:

[PDF - 239.87 KB]
Isoniazid Preventive Therapy and Risk for Resistant Tuberculosis

[PDF - 223.08 KB]

Personal Author:

Balcells, Maria Elvira ; Thomas, Sara L. ; ...

Published Date:

May 2006

Source:

Emerg Infect Dis. 12(5):744-751.

Description:

In the context of tuberculosis (TB) resurgence, isoniazid preventive therapy (IPT) is increasingly promoted, but concerns about the risk for developme...

File Type:

[PDF - 223.08 KB]

File Type:

[PDF - 223.08 KB]
A new era for treatment of drug-resistant tuberculosis

[PDF - 116.57 KB]

Personal Author:

Gandhi, Neel R. ; Brust, James C.M. ; ...

Published Date:

October 04 2018

Source:

Eur Respir J. 52(4)

File Type:

[PDF - 116.57 KB]

File Type:

[PDF - 116.57 KB]

Global isoniazid resistance patterns in rifampin-resistant and rifampin-susceptible tuberculosis

Global isoniazid resistance patterns in rifampin-resistant and rifampin-susceptible tuberculosis

You May Also Like:

Have Questions?

CDC INFORMATION

CONNECT WITH CDC